Jiangzhong Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio
Jiangzhong Pharmaceutical Co Ltd cash flow-to-debt ratio. Jiangzhong Pharmaceutical Co Ltd (600750) has a Cash Flow-to-Debt Ratio of 0.00x as of December 2025, meaning its operating cash flow of CN¥-2.91 Million could theoretically repay 0% of its total liabilities (CN¥2.18 Billion) in one year. Check 600750 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Jiangzhong Pharmaceutical Co Ltd (1998–2025)
Cash flow-to-debt ratio of Jiangzhong Pharmaceutical Co Ltd from 1998 to 2025. Historical debt coverage capacity for Jiangzhong Pharmaceutical Co Ltd across 28 annual periods. Check 600750 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Jiangzhong Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio by Year (1998–2025)
Jiangzhong Pharmaceutical Co Ltd cash flow-to-debt ratio by year from 1998 to 2025. Year-by-year debt coverage analysis for Jiangzhong Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see 600750 cash flow metrics.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.45x | CN¥970.87 Million | CN¥2.18 Billion | ▲ +15.5% |
| 2024 | 0.39x | CN¥786.25 Million | CN¥2.04 Billion | ▼ -33.9% |
| 2023 | 0.58x | CN¥1.04 Billion | CN¥1.77 Billion | ▲ +1.1% |
| 2022 | 0.58x | CN¥1.02 Billion | CN¥1.77 Billion | ▼ -10.8% |
| 2021 | 0.65x | CN¥917.04 Million | CN¥1.42 Billion | ▼ -42.1% |
| 2020 | 1.12x | CN¥752.50 Million | CN¥672.27 Million | ▲ +45.7% |
| 2019 | 0.77x | CN¥641.18 Million | CN¥834.84 Million | ▼ -11.0% |
| 2018 | 0.86x | CN¥486.25 Million | CN¥563.53 Million | ▲ +209.9% |
| 2017 | 0.28x | CN¥124.93 Million | CN¥448.74 Million | ▼ -82.1% |
| 2016 | 1.55x | CN¥698.05 Million | CN¥449.96 Million | ▼ -1.7% |
| 2015 | 1.58x | CN¥510.78 Million | CN¥323.74 Million | ▲ +427.9% |
| 2014 | 0.30x | CN¥356.80 Million | CN¥1.19 Billion | ▲ +129.4% |
| 2013 | 0.13x | CN¥111.92 Million | CN¥859.15 Million | ▼ -32.3% |
| 2012 | 0.19x | CN¥226.38 Million | CN¥1.18 Billion | ▼ -23.2% |
| 2011 | 0.25x | CN¥168.30 Million | CN¥671.11 Million | ▼ -18.0% |
| 2010 | 0.31x | CN¥222.29 Million | CN¥726.93 Million | ▼ -57.6% |
| 2009 | 0.72x | CN¥378.32 Million | CN¥524.73 Million | ▲ +65.4% |
| 2008 | 0.44x | CN¥268.87 Million | CN¥616.73 Million | ▲ +8.9% |
| 2007 | 0.40x | CN¥153.63 Million | CN¥383.89 Million | ▲ +312.9% |
| 2006 | 0.10x | CN¥55.24 Million | CN¥569.95 Million | ▼ -78.1% |
| 2005 | 0.44x | CN¥198.45 Million | CN¥449.20 Million | ▲ +743.4% |
| 2004 | 0.05x | CN¥26.28 Million | CN¥501.74 Million | ▼ -77.0% |
| 2003 | 0.23x | CN¥78.98 Million | CN¥347.14 Million | ▼ -60.3% |
| 2002 | 0.57x | CN¥94.90 Million | CN¥165.58 Million | ▲ +22.5% |
| 2001 | 0.47x | CN¥41.28 Million | CN¥88.23 Million | ▼ -37.5% |
| 2000 | 0.75x | CN¥121.77 Million | CN¥162.71 Million | ▲ +651.9% |
| 1999 | -0.14x | CN¥-21.89 Million | CN¥161.46 Million | ▼ -70.4% |
| 1998 | -0.08x | CN¥-11.42 Million | CN¥143.42 Million | — |